Test ID: OPRMO
Opioid Receptor, Mu 1 (OPRM1) Genotype for Naltrexone Efficacy, Saliva
NY State Approved 
Indicates the status of NY State approval and if the test is orderable for NY State clients.
Conditional
Useful For Suggests clinical disorders or settings where the test may be helpful
Identifying individuals with a higher probability of successful treatment for alcoholism with naltrexone
Testing Algorithm Delineates situation(s) when tests are added to the initial order. This includes reflex and additional tests.
Special Instructions and Forms Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test
Method Name A short description of the method used to perform the test
Polymerase Chain Reaction (PCR) 5'-Nuclease End-point Allelic Discrimination Analysis
(PCR is utilized pursuant to a license agreement with Roche Molecular System, Inc.)
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
OPRM1 Genotype, Naltrexone, Saliva
Aliases Lists additional common names for a test, as an aid in searching
Acamprosate Calcium (CAMPRAL)
CAMPRAL (Acamprosate Calcium)
MOR
Mu-Opioid Receptor (OPRM1)
Naltrexone
Opioid mu Receptor
OPRM1 (mu-Opioid Receptor)
CAMPRAL (Acamprosate Calcium)
MOR
Mu-Opioid Receptor (OPRM1)
Naltrexone
Opioid mu Receptor
OPRM1 (mu-Opioid Receptor)
External
link
PDF
document
Excel
document
Word
document